Fresh Recalls

FDAClass II · Drug · Recall D-0689-2026 · Recalled July 22, 2026

CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0 recall — Chiesi USA, Inc.

Agency report date: July 22, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0
Company / brand
Chiesi USA
Lot / serial / date codes
Lot #: 1239521, 1237454, Exp. Date 10/2027
Distribution
Nationwide within the United States
Agency product description and boundaries

CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Lack of Assurance of Sterility

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0

3. Open the official notice or contact

Official recall ID
D-0689-2026
Brand
Chiesi USA
Classification
Class II
Units affected
44280 vials
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Cary, NC, United States
Firm address
175 Regency Woods Pl Ste 600, 27518-6007

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 1239521, 1237454, Exp. Date 10/2027
Distribution
Nationwide within the United States
Firm notified the public via
Letter
FDA event ID
99376
Recall initiated
July 6, 2026
FDA classified
July 14, 2026
FDA report date
July 22, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page